We are live on ! Find out more
SPRB

Spruce Biosciences
SPRB

35 hedge funds and large institutions have $24.7M invested in Spruce Biosciences in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 36 → 35 (-1)

13% less capital invested

Capital invested by funds: $28.5M → $24.7M (-$3.75M)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
A
Abingworth
United Kingdom
+$3.34M
2
B
Bailard
California
+$39.4K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$21.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$16.6K
5
Citadel Advisors
Citadel Advisors
Florida
+$9.5K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$84K
2
Goldman Sachs
Goldman Sachs
New York
-$74.6K
3
Morgan Stanley
Morgan Stanley
New York
-$69.9K
4
E
Ergoteles
New York
-$35.2K
5
VF
Virtu Financial
New York
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$6.18M – – –
OFM
2
Omega Fund Management
Massachusetts
$2.96M – – –
RVM
3
RiverVest Venture Management
Missouri
$2.94M – – –
A
4
Abingworth
United Kingdom
$2.47M +$3.34M +23,900 New
Citadel Advisors
5
Citadel Advisors
Florida
$2.37M +$9.5K +68 +0.3%
RSCM
6
Rock Springs Capital Management
Maryland
$2.22M – – –
ACM
7
Aisling Capital Management
New York
$1.65M – – –
LGM
8
Logos Global Management
California
$1.37M – – –
SCV
9
Sands Capital Ventures
Virginia
$1.08M – – –
BlackRock
10
BlackRock
New York
$205K -$11.6K -83 -4%
Millennium Management
11
Millennium Management
New York
$199K -$84K -601 -24%
Renaissance Technologies
12
Renaissance Technologies
New York
$196K -$15.5K -111 -5%
Vanguard Group
13
Vanguard Group
Pennsylvania
$171K +$16.6K +119 +8%
State Street
14
State Street
Massachusetts
$128K – – –
Bank of New York Mellon
15
Bank of New York Mellon
New York
$127K – – –
MAM
16
Marquette Asset Management
Minnesota
$88K – – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$83K – – –
BCM
18
Bridgeway Capital Management
Texas
$82K – – –
E
19
Ergoteles
New York
$32K -$35.2K -252 -45%
Morgan Stanley
20
Morgan Stanley
New York
$31K -$69.9K -500 -62%
B
21
Bailard
California
$29K +$39.4K +282 New
Goldman Sachs
22
Goldman Sachs
New York
$27K -$74.6K -534 -67%
Northern Trust
23
Northern Trust
Illinois
$19K – – –
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$16K +$21.9K +157 New
Barclays
25
Barclays
United Kingdom
$15K – – –
1
2

SPRB Hedge Fund Activity: Q3 2022 in Review

35 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q3 2022, worth a combined $24.7M — down 13% from $28.5M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SPRB and 3 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 6 added.

The largest buyer was Abingworth, opening a new position worth an estimated $3.34M. The largest seller was Millennium Management, cutting an estimated $84K.

  • 35 institutional investors held Spruce Biosciences (SPRB) as of Q3 2022, down from 36 in Q2 2022.
  • Funds reported $24.7M of Spruce Biosciences stock for Q3 2022, down 13% quarter-over-quarter.
  • 3 funds opened new Spruce Biosciences positions in Q3 2022 and 4 closed out, a net change of -1 holder.
  • The largest Spruce Biosciences buyer in Q3 2022 was Abingworth, an estimated $3.34M added.
  • The largest Spruce Biosciences seller in Q3 2022 was Millennium Management, an estimated $84K sold.

Based on aggregated 13F filings for Q3 2022.